NCT04924062
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study treatment 3 active_not_recruiting NCT06048133
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) treatment 2 recruiting NCT06047990
Endobiliary Percutaneous Cryobiopsy in Malignant Biliary Obstruction No drug interventions diagnostic Not Available recruiting NCT02151084
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer treatment 2 active_not_recruiting NCT03027284
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer treatment 1 completed NCT06199882
SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma treatment 2 recruiting NCT02105350
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer treatment 1 withdrawn NCT05668884
GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma treatment 2 recruiting NCT05845554
Application of Chromosomal Instability in Early Diagnosis of Biliary Tract Carcinoma No drug interventions Not Available Not Available recruiting NCT05822453
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma treatment 2 not_yet_recruiting NCT05023109
GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC No drug interventions treatment 2 active_not_recruiting NCT05064852
A Real-world Study of the Safety and Efficacy of Surufatinib in the Treatment of Biliary Tract Carcinoma Not Available Not Available unknown_status NCT00490399
Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas treatment 2 completed NCT04003636
Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966) treatment 3 active_not_recruiting NCT04003896
A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma treatment 2 terminated NCT04979663
GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer treatment 1 / 2 unknown_status NCT06463548
Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma treatment Not Available not_yet_recruiting NCT05123482
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies treatment 1 / 2 recruiting NCT06430827
Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma treatment 2 not_yet_recruiting NCT04178460
A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment treatment 1 terminated NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer No drug interventions screening 0 completed NCT04984980
Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer treatment 2 active_not_recruiting NCT06168292
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma No drug interventions treatment Not Available not_yet_recruiting NCT06349044
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. treatment Not Available recruiting NCT06530823
Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma treatment 2 not_yet_recruiting